Adoptive immunotherapy of cancer using monocyte-derived macrophages: Rationale, current status, and perspectives

Journal of Leukocyte Biology

Volumn 64, Issue 4, 1998, Pages 419-426

  Andreesen, Reinhard ^a   Hennemann, Burkhard ^a   Krause, Stefan W ^a  

^a UNIVERSITY OF REGENSBURG   (Germany)

Author keywords

Cellular vaccine; Dendritic cells; Tumor cytotoxicity

Indexed keywords

GAMMA INTERFERON; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; LIPOPOLYSACCHARIDE;

ADOPTIVE IMMUNOTHERAPY; ADOPTIVE TRANSFER; ANTIGEN PRESENTING CELL; CANCER IMMUNOTHERAPY; CANCER PATIENT; DENDRITIC CELL; EFFECTOR CELL; HOST RESISTANCE; HUMAN; HUMAN CELL; MACROPHAGE ACTIVATION; MONOCYTE; PRIORITY JOURNAL; REVIEW; TARGET CELL; TUMOR GROWTH;

MURINAE; MYCOBACTERIUM AVIUM COMPLEX (MAC);

EID: 0031691590     PISSN: 07415400     EISSN: None     Source Type: Journal    
DOI: 10.1002/jlb.64.4.419     Document Type: Review

References (82)

1. Kolb, H. J., Mittermüller, J., Clemm, C., Holler, E., Ledderose, G., Brehm, G., Heim, M., Wilmanns, W. (1990) Donor leukocyte transfusions for treatment of recurrent chronic myelogenous leukemia in marrow transplant patients. Blood 76, 2462-2465.
2. Collins, R. H., Shpilberg, O., Drobsky, W. R., Porter, D. L., Giralt, S., Champlin, R., Goodman, S. A., Wolff, S. N., Hu, W., Verfailie, C., List, A., Dalton, W., Ognoskie, N., Chetrit, A., Antin, J. H., Nemunaitis, J. (1997) Donor leukocyte infusions in 140 patients with relapsed malignancy after allogeneic bone marrow transplantation. J. Clin. Oncol. 15, 433-444.
3. Rooney, C. M., Smith, C. A., Ng, C. Y. C., Loftin, S., Li, C., Krance, R. A., Brenner, M. K., Heslop, H. E. (1995) Use of gene-modified virus-specific T lymphocytes to control Epstein-Barr-Virus-related lymphoproliferation. Lancet 345, 9-13.
4. Papadopoulos, E., Ladanyi, M., Emanuel, D., Mackinnon, S., Boulad, F., Carabasi, M. H., Castro-Malaspina, H., Childs, B. H., Gillio, A. P., Small, T. N., Young, J. W., Kernan, N. A., O'Reilly, R. J. (1994) Infusions of donor leukocytes to treat Epstein-Barr virus-associated lymphoproliferative disorders after allogeneic bone marrow transplantation. N. Engl. J. Med. 330, 1185-1191.
5. Heslop, H. E., NG, C. Y.C., Li, C., Smith, C. A., Loftin, S. K., Krance, R. A., Brenner, M. K., Rooney, C. M. (1996) Long-term restoration of immunity against Epstein-Barr virus infection by adoptive transfer of gene-modified virus-specific T-lymphocytes. Nature Med. 5, 551-555.
6. Walter, E. A., Greenberg, P. D., Gilbert, M. J., Finch, R. J., Watanabe, K. S., Thomas, E. D., Riddell, S. R. (1995) Reconstitution of cellular immunity against cytomegalovirus in recipients of allogeneic bone marrow by transfer of T-cell clones from the donor. N. Engl. J. Med. 332, 1038-1044.
7. Mackaness, G. B. (1970) The monocyte in cellular immunity. Semin. Hematol. 7, 172-184.
8. Fidler, I. J., Kleinermann, E. S. (1984) Lymphokine-activated human blood monocytes destroy tumor cells but not normal cells under cocultivation conditions. J. Clin. Oncol. 2, 937-943.
9. Somers, S. D., Johnson, W. J., Adams, D. O. (1986) Destruction of tumor cells by macrophages: Mechanisms of recognition and lysis and their regulation. In Cancer Immunology: Innovative Approaches to Therapy (R. B. Herberman, ed.) Boston: Martinus Nijhoff.
10. Mantovani, A., Bottazzi, B., Colotta, F., Sozzani, S., Ruco, L. (1992) The origin and function of tumor-associated macrophages. Immunol. Today 13, 265-270.
11. Mantovani, A., Wang, J. M., Balotta, C., Abdeljalil, B., Bottazzi B. (1986) Origin and regulation of tumour-associated macrophages: the role of tumour-derived chemotactic factor. Biochem. Biophys. Acta 865, 59-67.
12. Polverini, P. J., Leibovich, S. J. (1984) Induction of neovascularization in vivo and endothelial proliferation in vitro by tumor-associated macrophages. Lab. Invest. 51, 635-642.
13. De Baetselier, P., Kapon, A., Katzav, S. (1985) Non-metastatic tumour cells acquire metastatic properties following somatic hybridization with normal cells. Cancer Metastat. Rev. 3, 5-24.
14. Balkwill, F., Burke, F., Talbot, D., Tavernier, J., Osborne, R., Naylor, S., Durbin, H., Fiers, W. (1987) Evidence for tumor necrosis factor/cachectin production in cancer. Lancet 2, 1229-1232.
15. Leek, R. D., Lewis, C. E., Whitehouse, R., Greenall, M., Clarke, J., Harris, A. L. (1996) Association of macrophage infiltration with angiogenesis and prognosis in invasive breast carcinoma. Cancer Res. 56, 4625-4629.
16. Russell, S. W., McIntosh, A. T. (1977) Macrophages isolated from regressing Moloney sarcomas are more cytotoxic than recovered from progressing sarcomas. Nature 268, 69-71.
17. Fidler, I. J., Ray, A., Fogler, W. E. Kirsh, R., Bugelski, P., Poste, G. (1980) Therapy of spontaneous metastases by intravenous injection of liposomes containing lymphokines. Science 108, 1469-1471.
18. Fidler, I. J. (1985) Macrophages and metastasis - a biological approach to cancer therapy. Cancer Res. 45, 4714-4726.
19. Fidler, I. J. (1974) Inhibition of pulmonary metastasis by intravenous injection of specifically activated and macrophages. Cancer Res. 34, 1074-1078.
20. Berdel, W. E., Bausert, W. R., Weltzien, H. U., Modolell, M. L., Widmann, K. H., Munder, P. G. (1980) The influence of alkyl-lysophospholipids and lysophospholipid-activated macrophages on the development of metastasis of 3-Lewis lung carcinoma. Eur. J. Cancer 16, 1199-1204.
21. Bartholeyns, J., Lombard, Y., Poindron, P. (1988) Immunotherapy of murine sarcoma by adoptive transfer of resident peritoneal macrophages proliferating in culture. Anticancer Res. 8, 145-151.
22. Chakraborty, N. G., Okino, T., Stabach, P., Padula, S. J., Yamase, H., Morse, E., Sha'afi, R. I., Twardzik, D. R., Shultz, L. J., Mukherji, B. (1991) Adoptive transfer of activated human autologous macrophages results in regression of transplanted human melanoma cells in SCID mice. In Vivo 5, 609-614.
23. Ortaldo, J. R., Porter, H. R, Miller, P., et al. (1986) Adoptive cellular immunotherapy of human ovarian carcinoma xenografts in nude mice. Cancer Res. 46, 4414-4419.
24. Stevenson, H. C., Miller, P., Akiyama, Y., Favilla, T., Beman, J. A., Herberman, R., Stull, H., Thurman, G., Maluish, A., Oldham, R. (1983) A system for obtaining large numbers of cryopreserved human monocytes purified by leukapheresis and counter-current centrifugation elutriation (CCE). J. Immunol. Meth. 62, 353-363.
25. Miller, P. J., Beman, J., Delawter, T., Stevenson, H. C. (1985) Multivariate analysis of the factors associated with the yield and purity of human monocyte isolation by countercurrent centrifugal elutriation. J. Immunopharmacol. 7, 99-123.
26. Lacerna, L. V., Jr., Stevenson, G. W., Stevenson, H. C. (1988) Adoptive cancer immunotherapy utilizing lymphokine activated killer cells and gamma interferon activated killer monocytes. Pharmacol. Ther. 38, 453-465.
27. Stevenson, H. C., Keenan, A. M., Woodhouse, C., Ottow, R. T., Miller, P., Steller, E. P., Foon, K. A., Abrams, P. G., Beman, J., Larson, S. M., et al. (1987) Fate of gamma-interferon-activated killer blood monocytes adoptively transferred into the abdominal cavity of patients with peritoneal carcinomatosis. Cancer Res. 47, 6100-6103.
28. Andreesen, R., Picht, J, Löhr, G. W. (1983) Primary cultures of human blood-born macrophages grown on hydrophobic teflon membranes. J. Immunol. Meth. 56, 295-304.
29. Andreesen, R., Brugger, W., Gadd, S., Löhr, G. W., Atkins, R. C. (1988) Activation of human monocyte-derived macrophages cultured on teflon: response to Interferon-γ during terminal maturation in vitro. Immunobiol. 177, 186-198.
30. Scheibenbogen, C., Andreesen, R. (1991) Developmental regulation of the cytokine repertoire in human macrophages: IL-1, IL-6, TNF-alpha and M-CSF. J. Leukoc. Biol. 50, 35-42.
31. Harwix, S., Andreesen, R., Ferber, E., Schwamberger, G. (1991) Human macrophages secrete a tumoricidal activity distinct from tumor necrosis factor alpha and reactive nitrogen intermediates. Res Immunol. 143, 89-94.
32. Andreesen, R., Osterholz, J., Bross, K. J., Schulz, A., Löhr, G. W. (1983) Cytotoxic effector cell function at different stages of human monocyte-macrophage maturation. Cancer Res. 43, 5931-5936.
33. Krause, S. W., Kreutz, M., Andreesen, R. (1998) Isolation, characterization and cultivation of human monocytes and macrophages. In Methods in Microbiology, vol. 25 (S. H. E. Kaufmann and D. Kabelitz, eds.), New York: Academic Press, 663-684.
34. Andreesen, R., Bross, K. J., Osterholz, J., Emmrich, F. (1986) Human macrophage maturation and heterogeneity: analysis with a newly generated set of monoclonal antibodies to differentiation antigens. Blood 67, 1257-1264.
35. Andreesen, R., Brugger., W, Scheibenbogen C., Kreutz, M., Leser, H. G., Rehm, A., Löhr, G. W. (1990) Surface phenotype analysis of human monocyte to macrophage maturation. J. Leukoc. Biol. 47, 490-497.
36. Munn, D., Cheung, N. K. (1989) Antibody-dependent antitumor cytotoxicity by human monocytes cultured with recominant macrophages colony-stimulating factor. J. Exp. Med. 170, 511-526.
37. Brugger, W., Scheibenbogen, C., Krause, S., Andreesen, R. (1991) Large-scale production of human macrophages grown from blood monocytes of cancer patients. Cancer Detect. Prevent. 407, 411.
38. Faradji, A., Bohbot, A., Schmitt-Goguel, M., Siffert, J. C., Dumont, S., Wiesel, M. L., Piemont, Y., Eischen, A., Bergerat, J. P., Bartholeyns, J. et al. (1994) Large scale isolation of human blood monocytes by continuous flow centrifugation leukapheresis and counterflow centrifugation elutriation for adoptive cellular immunotherapy in cancer patients. J. Immunol. Meth. 174, 297-309.
39. Eischen, A., Vincent, F., Bergerat, J. P., Louis, B, Faradji, A., Bohbot, A., Oberling, F. (1991) Long term cultures of human monocytes in vitro. Impact of GM-CSF on survival and differentiation. J. Immunol. Meth. 143, 209-221.
40. Vincent, F., Eischen, A., Bergerat, J. P., Faradji, A., Bohbot, A., Oberling, F. (1992) Human blood-derived macrophages: differentiation in vitro of a large quantity of cells in serum-free medium. Exp. Hematol. 20, 17-23.
41. 3. Blood 76, 2457-2461.
42. Kreutz, M., Krause, S. W., Hennemann, B., Rehm, A., Andreesen, R. (1992) Macrophage heterogeneity and differentiation - defined serum-free culture conditions induce different types of macrophages in vitro. Res. Immunol. 143, 107-115.
43. Andreesen, R., Scheibenbogen, C., Brugger, W., Krause, S., Meerpohl., H. G., Leser, H. G., Engler, H., Löhr, G. W. (1990) Adoptive transfer of tumor cytotoxic macrophages generated in vitro from circulating blood monocytes: a new approach to cancer immunotherapy. Cancer Res. 50, 7450-7456.
44. Faradji, A., Bohbot, A., Schmitt, N., Roeslin, N., Dumont, S., Wiesel, M., Lallot, C., Eber, M., Bartholeyns, J., Poindron, P., Morand, G., Witz, J., Oberling, F. (1991) Phase 1 trial of IV infusion of ex-vivo activated blood derived macrophages in patients with non-small cell lung cancer: toxicity and immunomodulatory effects. Cancer Immunol. Immunother. 33, 319.
45. Faradji, A., Bohbot, A., Frost, H., Schmitt-Goguel, M. Siffert, J. C., Dufour, P., Eber, M., Lallot, C., Wiesel, M. L., Bergerat, J. P., Oberling, F. (1991) Phase I study of liposomal MTP-PE-activated autologous monocytes administered intraperitoneally to patients with peritoneal carcinomatosis. J. Clin. Oncol. 9, 1251-1260.
46. Lopez, M., Fechtenbaum, J., David, B., Martinache, C., Chokri,. M., Canepa, S., De-Gramot, A., Louvet, C., Gorin, I., Mortel, O., et al. (1992) Adoptive immunotherapy with activated macrophages grown in vitro from blood monocytes in cancer patients: a pilot study. J. Immunother. 11, 209-217.
47. Eymard, J. C., Lopez, M., Cattan, A., Bouché, O., Adjizian, J. C., Bernard, J. (1996) Phase I/II trial of autologous activated macrophages in advanced colorectal cancer. Eur. J. Cancer 11, 1905-1911.
48. Wiesel, M. L., Faradji, A., Grunebaum, L., Bohbot, A., Schmitt-Goguel,. M., Bergerat, J. P., Cazenave, J. P., Oberling, F. (1992) Hemostatic changes in human adoptive immunotherapy with activated blood monocytes or derived macrophages. Ann. Hematol. 65, 78-80.
49. Lopez, M., Louvet, C., Martinache, C., Bony, V., Scotto, F., Barelaud, S., Jiang, R., Drapier, J. C, Smadja, V., De-Gramont, A., et al. (1994) Infusion of large quantities of autologous blood monocyte-derived macrophages in two cancer patients did not induce increased concentration of IL-6, TNF-alpha, soluble CD14 and nitrate in blood plasma. Eur. Cytokine Netw. 5, 411-414.
50. Scheibenbogen, C., Moser, H., Krause, S., Andreesen, R. (1992) Interferon-gamma-induced expression of tissue factor activity during human monocyte to macrophage maturation. Haemostasis 22, 173-178.
51. Hennemann, B., Scheibenbogen, C., Schümichen, C., Andreesen, R. (1995) Intrahepatic adoptive immunotherapy with autologous tumorcytotoxic macrophages in patients with cancer. J. Immunother. 18, 19-27.
52. Hennemann, B., Rehm, A., Kottke, A., Meidenbauer, N., Andreesen, R. (1997) Adoptive immunotherapy with tumor-cytotoxic macrophages: phase I trial to study the mobilisation of blood monocytes with recombinant human granulocyte-macrophage colony-stimulating factor. J. Immunother. 20, 365-371.
53. Hennemann, B., Beckmann, G., Eichelmann, A., Rehm, A., Andreesen, R. (1997) Phase I trial of adoptive immunotherapy of cancer patients using monocyte-derived macrophages activated with Interferon-γ and LPS. Cancer Immunol. Immunother. 456, 250-256.
54. Chokri, M., Girard, A., Borrelly, M. C., Oleron, C., Romet-Lemonne, J. L., Bartholeyns, J. (1992) Adoptive immunotherapy with bispecific antibodies: targeting through macrophages. Res. Immunol. 143, 95-99.
55. Somasundaram, C., Ach, R., Matzku, S., Zoller, M. (1996) Development of a bispecific F (ab*) 2 conjugate against the complement receptor CR3 of macrophages and a variant CD44 antigen of rat panceatic adenocarcinoma for redirecting macrophage-mediated tumor cytotoxicity. Cancer Immunol. Immunother. 42, 343-350.
56. Toujas, L., Delcros, J. G., Diez, E., Gervois, N., Semana, G., Corradin, G., Jotereau, F. (1997) Human monocyte-derived macrophages and dendritic cells are comparably effective in vitro in presenting HLA class I-restricted exogenous peptides. Immunol. 91, 635-642.
57. Haddada, H., Lopez, M., Martinache, C., Ragot, T., Abina, M. A., Perricaudet, M. (1993) Efficient adenovirus-mediated gene transfer into human blood monocyte-derived macrophages. Biochem. Biophys. Res. Commun. 195, 1174-1183.
58. Aicher, A., Westermann, J., Cayeux, S., Willimsky, G., Daemen, K., Blankenstein, T., Uckert, W., Dörken, B., Pezzutto, A. (1997) Successful retroviral mediated transduction of a reporter gene in human dendritic cells: Feasibility of therapy with gene-modified antigen presenting cells. Exp. Hematol. 23, 39-44.
59. Arthur, J. F., Butterfield, L. H., Roth, M. D., Bui, L. A., Kiertscher, S. M., Lau, R., Dubinett, S., Glaspy, J., McBride, W. H., Economou, J. S. (1996) A comparison of gene transfer methods in human dendritic cells. Cancer Gene Ther. 4, 17-25.
60. Peter, J. H., Ruhland, S., Friedrichs, D. (1987) Veiled accessory cells deduced from monocytes. Immunobiol. 176, 154.
61. Peters, H. J., Gieseler, R., Thiele, B, Steinbach, F. (1996) Dendritic cells: from ontogenetic orphans to myelomonocytic descendants. Immunol. Today 6, 273-278.
62. + dendritic cells. Proc. Natl. Acad. Sci. USA 93, 2588.
63. + peripheral blood monocytes. J. Immunol. 175, 3850.
64. Romani, N., Reider, D., Heuer, M., Ebner, S., Kampgen, E., Eibl, B., Niederwieser, D., Schuler, G. (1996) Generation of mature dendritic cells from human blood: an improved method with special regard to clinical applicability. J. Immunol. Meth. 196, 137.
65. + hematopoietic progenitor cells. Immunobiol. 198, 501-513.
66. Nestle, F. O., Alijagic, S., Gilliet, M., Yuansheng, S., Grabbe, S., Dummer, R., Burg, G., Schadendorf, D. (1998) Vaccination of melanoma patients with peptide- or tumor lysate-pulsed dendritic cells. Nature Med. 4, 328-332.
67. Manickan, E., Kanangat, S., Rouse, R. J. D., Zhiya, Yu. (1997) Enhancement of immune response to naked DNA vaccine by immunization with transfected dendritic cells. J. Leukoc. Biol. 61, 125.
68. Celluzzi, C. M., Mayordomo, J. I., Storkus, W. J., Lotze, M. T., Falo, L. D. (1996) Peptide-pulsed dendritic cells induce antigen-specific, CTL-mediated protective tumor immunity. J. Exp. Med. 183, 283-287.
69. Zitvogel, L., Mayordomo, J. I., Tjandrawan, T., DeLeo, A. B., Clarke, R., Lotze, M. T., Storkus, W. J. (1996) Therapy of murine tumors with tumor peptide-pulsed dendritic cells: dependence on T cells, B7 costimulation, and T helper cell-associated cytokines. J. Exp. Med. 183, 87-97.
70. Nair, S. K, Snyder, D., Rouse, B. T., Gilboa, E. Regression of tumors in mice vaccinated with professional antigen-presenting cells pulsed with tumor extracts. Int. J. Cancer 70, 206-215.
71. Gong, J., Dongshu, Ch., Kashiwaba, M., Kufe, D. (1997) Induction of antitumor activity by immunization with fusions of dendritic and carcinoma cells. Nature Med. 3, 558.
72. Grabbe, S., Beissert, S., Schwarz, T., Granstein, R. D. (1995) Dendritic cells as initiators of tumor immune responses: a possible strategy for tumor immunotherapy? Immunol. Today 16, 117-121.
73. Troy, A. J., Hart, D. N. J. (1997) Dendritic cells and cancer: Progress toward a new cellular therapy. J. Hemother. 6, 523-532.
74. Smith, W. M., Rijnbeek, M., van Bergen, C. A., de Paus, R. A., Vervenne, H. A., van de Keur, M., Willemze, R., Falkenburg, J. H. (1997) Generation of dendritic cells expressing bcr-abl from CD34-positive chronic myeloid leukemia precursor cells. Human Immunol. 53, 216-223.
75. Finkelmann, F. D., Lees, A., Birnbaum, R., Gause, W. C., Morris, S. C. (1996) Dendritic cells can present antigen in vivo in a tolerogenic or immunogenic fashion. J. Immunol. 157, 1406-1414.
76. Ferrero, I., Anjuère, F., Robson, H., MacDonald, R., Ardavin, C. (1997) In vitro negative selection of viral superantigen-reactive thymocytes by thymic dendritic cells. Blood 90, 1943-1951.
77. Ridge, J. P., Fuch, E. J., Matzinger, P. (1996) Neonatal tolerance revisited: turning on newborn T cells with dendritic cells. Science 271, 1723-1726.
78. Cardoso, A. A., Seamon, M. J., Afonso, H. M., Ghia, P., Boussiotis, V. A., Freeman, G. J., Gribben, J. G., Sallan, S. E., Nadler, L. M. (1997) Ex vivo generation of human anti-pre-B leukemia-specific autologous cytolytic T-cells. Blood 90, 549-561.
79. + T cells with cytotoxic activity against leukemia cells from patients with chronic myeloid leukemia. Blood 91, 997-983.
80. + T cells. J. Exp. Med. 184, 19-29.
81. + T-cell substet inhibits antigen-specific T-cell responses and prevents colitis. Nature 389, 737-742.
82. Krause, S. W., Kreutz, M., Zenke, G., Andreesen, R. (1992) Developmental regulation of granulocyte-macrophage colony-stimulating factor production during human monocyte to macrophage maturation. Ann. Hematol. 64, 190-195.